Investigating Lipidomic Determinants of Cognitive Impairment in Mouse Models of Alzheimer’s Disease
Alzheimer’s disease is an insidious neurodegenerative disease that affects millions of people worldwide. Currently, there are no determinants that can accurately predict the onset cognitive decline in AD. This thesis investigates and defines changes in the lipidome that are linked to symptomatic ons...
Main Author: | Granger, Matthew |
---|---|
Other Authors: | Bennett, Steffany A.L. |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/37984 http://dx.doi.org/10.20381/ruor-22241 |
Similar Items
-
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer’s Disease
by: Steffany A L Bennett, et al.
Published: (2013-07-01) -
The Effect of Rho Kinase Inhibitors on Alzheimer's Disease
Published: (2017) -
Comparison of different protocols of Morris water maze in cognitive impairment with heart failure
by: Ziwen Lu, et al.
Published: (2020-02-01) -
Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
by: Fatemeh Heidari Soureshjani, et al.
Published: (2020-09-01) -
Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
by: Adrian C. Lo, et al.
Published: (2013-02-01)